234 related articles for article (PubMed ID: 30294329)
1. Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells.
Irons EE; Lau JTY
Front Immunol; 2018; 9():2150. PubMed ID: 30294329
[TBL] [Abstract][Full Text] [Related]
2. Extrinsic sialylation is dynamically regulated by systemic triggers
Manhardt CT; Punch PR; Dougher CWL; Lau JTY
J Biol Chem; 2017 Aug; 292(33):13514-13520. PubMed ID: 28717006
[TBL] [Abstract][Full Text] [Related]
3. The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis.
Dougher CWL; Buffone A; Nemeth MJ; Nasirikenari M; Irons EE; Bogner PN; Lau JTY
J Leukoc Biol; 2017 Aug; 102(2):507-516. PubMed ID: 28550122
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene.
Jones MB; Nasirikenari M; Lugade AA; Thanavala Y; Lau JT
J Biol Chem; 2012 May; 287(19):15365-70. PubMed ID: 22427662
[TBL] [Abstract][Full Text] [Related]
5. Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase.
Nasirikenari M; Veillon L; Collins CC; Azadi P; Lau JTY
J Biol Chem; 2014 Mar; 289(10):7178-7189. PubMed ID: 24425878
[TBL] [Abstract][Full Text] [Related]
6. Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis.
Jones MB; Nasirikenari M; Feng L; Migliore MT; Choi KS; Kazim L; Lau JT
J Biol Chem; 2010 Aug; 285(32):25009-17. PubMed ID: 20529847
[TBL] [Abstract][Full Text] [Related]
7. Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.
Britain CM; Holdbrooks AT; Anderson JC; Willey CD; Bellis SL
J Ovarian Res; 2018 Feb; 11(1):12. PubMed ID: 29402301
[TBL] [Abstract][Full Text] [Related]
8. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
Holdbrooks AT; Britain CM; Bellis SL
J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
[TBL] [Abstract][Full Text] [Related]
9. The generation of influenza-specific humoral responses is impaired in ST6Gal I-deficient mice.
Zeng J; Joo HM; Rajini B; Wrammert JP; Sangster MY; Onami TM
J Immunol; 2009 Apr; 182(8):4721-7. PubMed ID: 19342648
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells.
Chen X; Wang L; Yu X; Wang S; Zhang J
Int J Biochem Cell Biol; 2021 Aug; 137():106027. PubMed ID: 34157397
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.
Lee M; Park JJ; Ko YG; Lee YS
Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099
[TBL] [Abstract][Full Text] [Related]
12. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.
Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD
Mol Cell Biol; 2006 Jul; 26(13):4970-81. PubMed ID: 16782884
[TBL] [Abstract][Full Text] [Related]
13. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death.
Amano M; Galvan M; He J; Baum LG
J Biol Chem; 2003 Feb; 278(9):7469-75. PubMed ID: 12499376
[TBL] [Abstract][Full Text] [Related]
14. Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.
Appenheimer MM; Huang RY; Chandrasekaran EV; Dalziel M; Hu YP; Soloway PD; Wuensch SA; Matta KL; Lau JT
Glycobiology; 2003 Aug; 13(8):591-600. PubMed ID: 12672700
[TBL] [Abstract][Full Text] [Related]
15. Blood-Borne ST6GAL1 Regulates Immunoglobulin Production in B Cells.
Irons EE; Punch PR; Lau JTY
Front Immunol; 2020; 11():617. PubMed ID: 32391003
[TBL] [Abstract][Full Text] [Related]
16. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-dependent inhibition of B cell proliferation requires CD22.
Santos L; Draves KE; Boton M; Grewal PK; Marth JD; Clark EA
J Immunol; 2008 Apr; 180(7):4561-9. PubMed ID: 18354178
[TBL] [Abstract][Full Text] [Related]
18. Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms.
Wuensch SA; Huang RY; Ewing J; Liang X; Lau JT
Glycobiology; 2000 Jan; 10(1):67-75. PubMed ID: 10570225
[TBL] [Abstract][Full Text] [Related]
19. Protein sialylation by sialyltransferase involves radiation resistance.
Lee M; Lee HJ; Bae S; Lee YS
Mol Cancer Res; 2008 Aug; 6(8):1316-25. PubMed ID: 18708363
[TBL] [Abstract][Full Text] [Related]
20. α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
Wang L; Li S; Yu X; Han Y; Wu Y; Wang S; Chen X; Zhang J; Wang S
J Physiol Biochem; 2019 Jun; 75(2):199-207. PubMed ID: 30972697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
